The association of autosomal dominant optic atrophy and moderate deafness may be due to the R445H mutation in the OPA1 gene
- PMID: 14644237
- DOI: 10.1016/s0002-9394(03)00665-2
The association of autosomal dominant optic atrophy and moderate deafness may be due to the R445H mutation in the OPA1 gene
Abstract
Purpose: To examine the involvement of the optic atrophy 1 (OPA1) gene in optic atrophy associated with moderate deafness.
Design: Observational case report. The entire coding sequence of the OPA1 gene was directly sequenced in the case of a patient suffering from optic atrophy associated with moderate deafness.
Results: A de novo heterozygous mutation R445H in the OPA1 gene was found. No similar mutation was detected in either of the patient's parents or in the 100 chromosome controls.
Conclusion: The R445H mutation in OPA1 might be the cause of the association between dominant optic atrophy and moderate deafness, a phenotype that may be currently underdiagnosed.
Similar articles
-
A novel mutation in the OPA1 gene in a Japanese patient with optic atrophy.Am J Ophthalmol. 2003 Feb;135(2):256-7. doi: 10.1016/s0002-9394(02)01929-3. Am J Ophthalmol. 2003. PMID: 12566046
-
OPA1 R445H mutation in optic atrophy associated with sensorineural deafness.Ann Neurol. 2005 Dec;58(6):958-63. doi: 10.1002/ana.20681. Ann Neurol. 2005. PMID: 16240368
-
Novel mutations of the OPA1 gene in Chinese dominant optic atrophy.Ophthalmology. 2010 Feb;117(2):392-6.e1. doi: 10.1016/j.ophtha.2009.07.019. Epub 2009 Dec 6. Ophthalmology. 2010. PMID: 19969356
-
Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1.Mol Med Rep. 2016 Jul;14(1):33-40. doi: 10.3892/mmr.2016.5209. Epub 2016 May 4. Mol Med Rep. 2016. PMID: 27150940 Free PMC article. Review.
-
OPA1: How much do we know to approach therapy?Pharmacol Res. 2018 May;131:199-210. doi: 10.1016/j.phrs.2018.02.018. Epub 2018 Feb 15. Pharmacol Res. 2018. PMID: 29454676 Review.
Cited by
-
Autosomal dominant optic atrophy with OPA1 gene mutations accompanied by auditory neuropathy and other systemic complications in a Japanese cohort.Mol Vis. 2019 Oct 5;25:559-573. eCollection 2019. Mol Vis. 2019. PMID: 31673222 Free PMC article.
-
Saccharomyces cerevisiae as a Tool for Studying Mutations in Nuclear Genes Involved in Diseases Caused by Mitochondrial DNA Instability.Genes (Basel). 2021 Nov 24;12(12):1866. doi: 10.3390/genes12121866. Genes (Basel). 2021. PMID: 34946817 Free PMC article. Review.
-
Mutation spectrum of the OPA1 gene in a large cohort of patients with suspected dominant optic atrophy: Identification and classification of 48 novel variants.PLoS One. 2021 Jul 9;16(7):e0253987. doi: 10.1371/journal.pone.0253987. eCollection 2021. PLoS One. 2021. PMID: 34242285 Free PMC article.
-
Therapeutic Options in Hereditary Optic Neuropathies.Drugs. 2021 Jan;81(1):57-86. doi: 10.1007/s40265-020-01428-3. Drugs. 2021. PMID: 33159657 Free PMC article. Review.
-
Disturbed mitochondrial dynamics and neurodegenerative disorders.Nat Rev Neurol. 2015 Jan;11(1):11-24. doi: 10.1038/nrneurol.2014.228. Epub 2014 Dec 9. Nat Rev Neurol. 2015. PMID: 25486875 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
